Delivery Order SPE2DB25D9363-SPE2DB25FUFTD
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $22,268.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX 1 dose vials. This firm fixed-price delivery order was issued on September 4, 2025, with an ultimate completion date of September 25, 2025. The contract carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on its merits within the broader federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX 1 dose vials. This firm fixed-price delivery order was issued on August 27, 2025, with an ultimate completion date of September 18, 2025. The contract carries no set-aside designation, and performance will be completed at the vendor's Park Ridge location. This delivery order...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $2,161.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of YF-VAX 1 dose vials, with a completion date of September 7, 2021. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which runs through...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $36,186.15 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX 1 Dose Vials. The award, issued on July 29, 2025, with an ultimate completion date of August 19, 2025, utilizes firm fixed-price pricing and carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,113.42 by the Defense Logistics Agency (DLA) on September 2, 2025, for YF-VAX 1 dose vials. The award is a firm fixed-price delivery order with no set-aside designation, reflecting the company's competitive standing in federal pharmaceutical procurement. Performance is scheduled for completion by September 23, 2025, at the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials, with an ultimate completion date of September 3, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected under a firm fixed-price contract type with no set-aside designation. The products will be delivered to Park Ridge, Illinois and support the federal pharmaceutical supply chain...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $2,783.55 by the Defense Logistics Agency (DLA) on September 10, 2025, for the supply of YF-VAX 1 dose vials. This firm fixed-price delivery order, with an ultimate completion date of October 1, 2025, carries no set-aside designation and represents a specific product requisition fulfilled under DMS Pharmaceutical Group's broader...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order worth $2,161.50 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The order is for the YF-VAX 1 dose vaccine vials and has a completion date of November 30, 2021. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program, which covers a comprehensive range of pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX 1 dose vials with a ceiling value of $5,567.10. This firm fixed-price delivery order, issued on August 8, 2025, falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA valued at $499,999,999 and valid through November 2026. The contract carries no set-aside...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,783.55 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX 1 dose vials. The contract is a firm fixed-price delivery order with an ultimate completion date of September 24, 2025, and was awarded on September 3, 2025. This award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the federal...
- SPE2DB25D9363Indefinite Delivery Contract
- SPE2DB25D9363-SPE2DB25FUFTDDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of YF-VAX 1 dose vials. This firm fixed-price delivery order, issued on September 12, 2025, with an ultimate completion date of October 3, 2025, was awarded without a set-aside designation. The product will be performed and delivered from the awardee's Park Ridge location to support federal pharmaceutical supply requirements. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.999 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products for military health facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively across DLA's extensive medical supply procurement needs, which encompass branded and generic prescription drugs, biologics, vaccines, and medical consumables supporting Department of Defense healthcare operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/12/25 |